Navigation Links
Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study of Amigal(TM) for Fabry Disease
Date:2/11/2010

e successful.  Our focus is the completion of enrollment in Study 011 this year and the commencement of Study 012.  We are also very encouraged by the results of our preclinical studies of the chaperone-ERT combination approach as well as the advancements with our Parkinson's program.  We look forward to moving these applications of our technology forward in 2010."

Preclinical Chaperone-ERT Combination Therapy Data

Today Amicus presented data from preclinical studies that evaluated the combination of migalastat HCl and ERT and AT2220 and ERT in mouse models of Fabry and Pompe disease, respectively.  Studies of both combinations demonstrated that co-administration of the chaperone with ERT resulted in prolonged half-life of ERT in the circulation, increased enzyme activity in cells and greater substrate reduction in target tissues compared to that seen with ERT alone.  

Preclinical Parkinson's Disease Data

Amicus also presented data from preclinical studies that evaluated the chaperone AT2101 in mouse models of Parkinson's disease. The studies demonstrated that treatment with AT2101 increased the activity of beta-glucocerebrosidase (GCase), prevented accumulation of alpha-synuclein in the brain and improved motor function as assessed in various behavioral tests.  The Company also reported that new compounds have been identified that improve on the properties of AT2101 and expand the range of doses and regimens that show motor improvement in mouse models of the disease.  

About Fabry Disease

Fabry disease is a lysosomal storage disorder caused by inherited genetic mutations in the GLA gene, which results in deficient activity of the enzyme alpha-galactosidase A (alpha-Gal A). Deficient alpha-Gal A activity leads to lysosomal accumulation of globotriaosylceramide (GL-3), which is believed to cause the various symptoms of Fabry di
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
2. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
3. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
4. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
5. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
6. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
7. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
8. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
9. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
10. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
11. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 24, 2013 3SBio Inc. ... "Company"), a leading China -based ... marketing biopharmaceutical products, announced today that, at an ... Company,s shareholders voted in favor of the proposal ... and plan of merger dated February 8, 2013, ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de ... ), un destacado desarrollador y fabricante de herramientas ... la diagnosis y tratamiento de la enfermedad vascular ... del ensayo ADVISE ( Ad enosine V ... E valuation) II durante la sesión de ensayo ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... th Annual  Healthcare Conference on Thursday, May 30, 2013, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... Md., Dec. 21, 2011 The U.S. Food and Drug ... Flex Massager, imported by King International and sold by ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) The Shoulder Flex Massager is ... over the Internet. It is intended to provide users with ...
... NEW YORK, Dec. 21, 2011   Delcath Systems, Inc. ... to the Company,s Medical Advisory Board. ... the International Liver Cancer Association (ILCA), Dr. Gores will ... drug induced liver pathology to our Medical Advisory Board," ...
Cached Medicine Technology:FDA: Do Not Use ShoulderFlex Massagers 2FDA: Do Not Use ShoulderFlex Massagers 3Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board 2Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board 3Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board 4
(Date:5/24/2013)... New York (PRWEB) May 24, 2013 ... 2010 DePuy hip recall continue to move forward in ... According to documents filed in California’s San Francisco Superior ... seeking an expedited trial of her DePuy hip lawsuit ... v. DePuy Orthopaedics, Inc., et al., No. CGC11508806; Calif. ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Western University ... its status of “Full Accreditation” for the next seven ... on Education (COE). , “This is a magnificent achievement, ... hard work and student outcomes,” said College of Veterinary ... express my appreciation to the faculty, staff, preceptors, and ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 With Memorial Day ... Amica Insurance is offering tips to help prevent ... National Fire Protection Association (NFPA) reports that gas grills ... and 2010. Charcoal or other solid-fueled grills, meanwhile, caused approximately ... As a result, Amica Insurance is sharing the following tips ...
(Date:5/24/2013)... E-Dentists.com has announced the launch of ... Media Surge, a leading medical Internet marketing agency. ... service will focus on providing dentists the help they ... their competitive keywords. The dental SEO analysis covers a ... on what their competitors are doing right. The goal ...
(Date:5/24/2013)... Drugs commonly used to treat glaucoma may cause droopy ... vision, according to a new study. The drugs, ... reduce eye pressure, have already been shown to cause ... researchers said, suggesting that the new findings could lead ... be conservative when prescribing these drugs, the researchers added, ...
Breaking Medicine News(10 mins):Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2
... into the gut, according to a study published this ... There are several drugs that would have more ... absorption by the lower intestine. However, in order to ... medication delivered by mouth must surmount several barriers including ...
... By Randy Dotinga HealthDay Reporter , THURSDAY, ... and older white Americans are sicker than their counterparts in ... long as the Brits, thanks to doctors and drugs. ... care from the health-care system," explained study co-author James P. ...
... biceps (LHB) tendinopathy, which is a pain and/or tearing ... and/or a rotator cuff tear. LHB tendinopahy can be ... Because of the variety of the causes and the ... examination, including radiographic imaging to determine the diagnosis and ...
... a safe, effective way of removing bowel tumours and ... colorectal cancer, according to researchers from the University of ... time in hospital and recover more quickly from the ... way of doing surgery does not make patients with ...
... that multiple antiepileptic drugs (AEDs) used by pregnant women ... their teenagers. The research team from Karolinska University Hospital ... exposure to AEDs in utero may have a negative ... Epilepsia , a journal published by Wiley-Blackwell on ...
... , WEDNESDAY, Nov. 3 (HealthDay News) -- Higher levels ... care for Medicare patients, a new study has found. ... and Information Set revealed wide variation across the United ... of inappropriate prescriptions for the elderly, said the researchers ...
Cached Medicine News:Health News:Colonic navigation 2Health News:Older Americans Sicker Than British Peers... 2Health News:5-year results show keyhole bowel cancer surgery is safe and effective 2Health News:Teens of epileptic moms display poor school performance 2Health News:Pricey Drugs May Not Mean Better Care 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: